MIRM
Mirum Pharmaceuticals, Inc.
MIRM trails on the overall score without a compensating advantage in the available component scores.
UNH
UnitedHealth Group Incorporated
UNH has the edge over MIRM overall, supported by stronger fundamentals and stronger modeled upside.
MIRM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Weak |
MIRM's revenue is currently healthy, but its profitability, cash flow and balance sheet are weak.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
MIRM PE Valuation
MIRM has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
MIRM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect MIRM's losses to grow, with revenue growing. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
MIRM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$15.46 | -$14.60 |
| Q2 2026 | -$14.54 | -$13.33 |
| Q1 2026 | -$13.60 | -$11.99 |
| Q4 2025 | -$0.47 | +$1.38 |
| Q3 2025 | -$0.86 | +$1.19 |
| Q2 2025 | -$1.21 | +$1.11 |
| Q1 2025 | -$1.61 | +$2.13 |
| Q4 2024 | -$1.85 | +$2.15 |
MIRM lost $15.46 per share over the past year, and its loss has widened in each of the last three quarters.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over MIRM on earnings quality, reporting a profit while its opponent remains loss making.
MIRM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $185.7M | +40% |
| Q2 2026 | $176.2M | +38% |
| Q1 2026 | $159.9M | +43% |
| Q4 2025 | $148.9M | +50% |
| Q3 2025 | $133M | +47% |
| Q2 2025 | $127.8M | +64% |
| Q1 2025 | $111.6M | +61% |
| Q4 2024 | $99.4M | +43% |
MIRM has the edge over UNH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -32% | -34 points |
| Q2 2026 | -24% | -20 points |
| Q1 2026 | -494% | -480 points |
| Q4 2025 | -3.1% | +21 points |
| Q3 2025 | 2% | +16 points |
| Q2 2025 | -3.9% | +27 points |
| Q1 2025 | -14% | +25 points |
| Q4 2024 | -24% | +23 points |
MIRM's operating margin was −32% last quarter, down 34 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over MIRM on profitability, with a higher operating margin.
MIRM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.6M | -114% |
| Q2 2026 | -$44.3M | -472% |
| Q1 2026 | -$229.4M | -$227.4M |
| Q4 2025 | $5.5M | +$10.6M |
| Q3 2025 | $39.5M | +938% |
| Q2 2025 | $11.9M | +$16.5M |
| Q1 2025 | -$2M | -113% |
| Q4 2024 | -$5.1M | +$11.5M |
MIRM has burned cash in most quarters: −$274M over the past year, against $44M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over MIRM on cash generation, producing positive trailing cash flow while its opponent burns cash.
MIRM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.2% | +2.7M shares |
| 1 year | +16% | +9.1M shares |
| 3 years | +61% | +25M shares |
| 5 years | +117% | +35.7M shares |
| Available history | +167% | +41.3M shares |
MIRM has 66M diluted shares, up 16% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over MIRM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
MIRM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | 6.2x | High |
MIRM's net debt is about 6.2 years of its operating earnings (EBITDA).
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
MIRM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.3 | Neutral |
| Stochastic | 43.7 | Neutral |
MIRM's weekly RSI is 49 (neutral) and its Stochastic is 44 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
MIRM PE vs Healthcare Sector
MIRM has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
MIRM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $86.4 | 8% above |
| 20 week MA | $98.1 | 4.9% below |
| 50 week MA | $95.4 | 2.2% below |
| 100 week MA | $75.2 | 24% above |
| 200 week MA | $52.8 | 77% above |
MIRM's trend is mixed: it's above three of its five weekly moving averages, and 77% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over MIRM on trend strength, trading above more of its moving averages.
MIRM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $25.9 | $18.3 | -30% |
| 2021 | $18.3 | $15.6 | -15% |
| 2022 | $15.6 | $18.2 | +17% |
| 2023 | $18.2 | $29.5 | +62% |
| 2024 | $29.5 | $41.6 | +41% |
| 2025 | $41.6 | $79.3 | +91% |
| 2026 YTD | $79.3 | $93.3 | +18% |
MIRM has finished higher in four of the last six years, two of them by more than 50%. It's up 18% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over MIRM on returns for 2026, with the stronger performance.